107 related articles for article (PubMed ID: 14533029)
1. Prognostic significance of Fas expression in retinoblastoma.
Shanmugam MP; Lakshmi A; Biswas J; Krishnakumar S
Ocul Immunol Inflamm; 2003 Jun; 11(2):107-13. PubMed ID: 14533029
[TBL] [Abstract][Full Text] [Related]
2. Nm23 expression in retinoblastoma.
Krishnakumar S; Lakshmi A; Shanmugam MP; Vanitha K; Biswas J
Ocul Immunol Inflamm; 2004 Jun; 12(2):127-35. PubMed ID: 15512982
[TBL] [Abstract][Full Text] [Related]
3. Expression of Fas ligand in retinoblastoma.
Krishnakumar S; Kandalam M; Mohan A; Iyer A; Venkatesan N; Biswas J; Shanmugam MP
Cancer; 2004 Oct; 101(7):1672-6. PubMed ID: 15378505
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness.
Deepa PR; Nalini V; Mallikarjuna K; Vandhana S; Krishnakumar S
Curr Eye Res; 2009 Dec; 34(12):1011-8. PubMed ID: 19958119
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma: expression of HLA-G.
Adithi M; Kandalam M; Ramkumar HL; Subramanian A; Venkatesan N; Krishnakumar S
Ocul Immunol Inflamm; 2006 Aug; 14(4):207-13. PubMed ID: 16911982
[TBL] [Abstract][Full Text] [Related]
6. The role of nitric oxide synthases and nitrotyrosine in retinoblastoma.
Adithi M; Nalini V; Krishnakumar S
Cancer; 2005 Apr; 103(8):1701-11. PubMed ID: 15754329
[TBL] [Abstract][Full Text] [Related]
7. EpCAM expression in retinoblastoma: a novel molecular target for therapy.
Krishnakumar S; Mohan A; Mallikarjuna K; Venkatesan N; Biswas J; Shanmugam MP; Ren-Heidenreich L
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4247-50. PubMed ID: 15557427
[TBL] [Abstract][Full Text] [Related]
8. Expression of high mobility group A2 protein in retinoblastoma and its association with clinicopathologic features.
Venkatesan N; Kandalam M; Pasricha G; Sumantran V; Manfioletti G; Ono SJ; Reddy MA; Krishnakumar S
J Pediatr Hematol Oncol; 2009 Mar; 31(3):209-14. PubMed ID: 19262251
[TBL] [Abstract][Full Text] [Related]
9. Histopathological features and P-glycoprotein expression in retinoblastoma.
Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
[TBL] [Abstract][Full Text] [Related]
10. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas.
Mu G; Liu H; Zhou F; Xu X; Jiang H; Wang Y; Qu Y
Hum Pathol; 2010 Apr; 41(4):493-502. PubMed ID: 20004941
[TBL] [Abstract][Full Text] [Related]
11. Expression of C-kit in retinoblastoma: a potential therapeutic target.
Barry RJ; de Moura LR; Marshall JC; Fernandes BF; Orellana ME; Antecka E; Martins C; Burnier MN
Br J Ophthalmol; 2007 Nov; 91(11):1532-6. PubMed ID: 17591671
[TBL] [Abstract][Full Text] [Related]
12. Expression of the lipogenic enzyme fatty acid synthase (FAS) in retinoblastoma and its correlation with tumor aggressiveness.
Camassei FD; Cozza R; Acquaviva A; Jenkner A; Ravà L; Gareri R; Donfrancesco A; Bosman C; Vadalà P; Hadjistilianou T; Boldrini R
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2399-403. PubMed ID: 12766036
[TBL] [Abstract][Full Text] [Related]
13. Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression.
Souza Filho JP; Martins MC; Caissie AL; Torres VL; Fernandes LH; Erwenne CM; Burnier MN
Clin Exp Ophthalmol; 2005 Jun; 33(3):279-84. PubMed ID: 15932532
[TBL] [Abstract][Full Text] [Related]
14. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
[TBL] [Abstract][Full Text] [Related]
15. The study of c-Src kinase and pStat3 protein expression in retinoblastoma.
Mohan A; Mallikarjuna K; Venkatesan N; Abhyankar D; Parikh PM; Krishnakumar S
Exp Eye Res; 2006 Oct; 83(4):736-40. PubMed ID: 16716300
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
Schwimer CJ; Prayson RA
Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility antigens and antigen-processing molecules in retinoblastoma.
Krishnakumar S; Sundaram A; Abhyankar D; Krishnamurthy V; Shanmugam MP; Gopal L; Sharma T; Biswas J
Cancer; 2004 Mar; 100(5):1059-69. PubMed ID: 14983503
[TBL] [Abstract][Full Text] [Related]
18. Leucine-Rich α-2-Glycoprotein-1 (LRG-1) Expression in Retinoblastoma.
Amer R; Tiosano L; Pe'er J
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):685-692. PubMed ID: 29392314
[TBL] [Abstract][Full Text] [Related]
19. Higher vessel densities in retinoblastoma with local invasive growth and metastasis.
Rössler J; Dietrich T; Pavlakovic H; Schweigerer L; Havers W; Schüler A; Bornfeld N; Schilling H
Am J Pathol; 2004 Feb; 164(2):391-4. PubMed ID: 14742245
[TBL] [Abstract][Full Text] [Related]
20. Expressions of Rac1, Tiam1 and Cdc42 in retinoblastoma.
Adithi M; Venkatesan N; Kandalam M; Biswas J; Krishnakumar S
Exp Eye Res; 2006 Dec; 83(6):1446-52. PubMed ID: 17027002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
